The neurotransmitter dopamine is implicated in diverse functions, including reward 15 processing, reinforcement learning and cognitive control. The tendency to discount future 16 rewards in value over time has long been discussed in the context of potential dopaminergic 17 modulation. Here we examined the effect of a single dose of the D2 receptor antagonist 18 Haloperidol (2mg) on temporal discounting. Our approach extends previous human 19 pharmacological studies in two ways. First, we applied state-of-the-art computational 20 modeling based on the drift diffusion model to comprehensively examine choice dynamics.
Introduction 34 Future rewards are discounted in value 1 such that humans and many animals prefer smaller-35 sooner (SS) rewards over lager-but-later (LL) rewards, a process referred to as temporal or 36 delay discounting. Steep temporal discounting of reward value is associated with a range of General procedure 137 The study consisted of two testing sessions performed on separate days. On the first day (T0) 138 participants completed a background screening and a set working memory tasks (see below). 139 On the second day (T1) participants received either placebo or haloperidol (2mg). In line 140 with the pharmacokinetics of haloperidol 34 testing on T1 was performed 5 hours after drug 141 administration to ensure appropriate plasma levels of haloperidol. During the first 2.5hrs, 142 participants where under constant observation and pulse as well as blood pressure levels were 143 checked 30 minutes and 2 hours after drug administration. During the waiting period, 144 participants filled out questionnaires on current mood and medication effects. Participants 145 then completed a number of unrelated tasks during a functional magnetic resonance imaging 146 (fMRI) scanning session (total scan-time 2.5 hrs.). Following scanning, they first completed 147 the temporal discounting task outlined below, followed by a set of working memory tasks Temporal discounting task 152 Participants performed 210 trials of a temporal discounting task where on each trial they made 153 a choice between a smaller-but-sooner (SS) reward available immediately, and a larger-but-154 later (LL) reward. SS and LL rewards were randomly displayed on the left and right sides of 155 the screen, and participants were free to make their choice at any time. For half the trials, the 156 SS reward consisted of 20€ and for the remaining trials the SS reward was fixed at 100€. 157 These trials were presented randomly intermixed. LL options were computed via all 158 combinations of a set of LL reward amounts (constructed by multiplying the SS reward with 159 [1.01, 1.02, 1.05, 1.10, 1.20, 1.50, 1.80, 2.50, 2, 3, 4, 5, 7, 10, 13]) and LL delays (1, 2, 3, 5, 160 8, 30, 60 days), yielding 105 trials in total per magnitude condition. As is typically the case 161 for temporal discounting tasks investigating magnitude effects 25 , all choices were 162 hypothetical.
164
Computational modeling 165 Temporal discounting model 166 We applied a simple single-parameter hyperbolic discounting model to describe how value (1) 169 Here, A t is the numerical reward amount of the LL option on trial t, D t is the LL delay in days 170 on trial t and I is an indicator variable that takes on a value of 1 for trials from the large-171 magnitude condition (SS amount = 100€) data and 0 for trials from the small-magnitude 172 condition (SS amount = 20€). The model has two free parameters: k is the hyperbolic 173 discounting rate from the large magnitude condition (modeled in log-space) and s k is a 174 weighting parameter that models the degree of change in discounting for small vs. large SS 175 rewards (i.e., higher values in s k reflect a greater magnitude effect 25 ). Here, SV is the subjective value of the risky reward according to Eq. 1 and is an inverse 182 temperature parameter, modeling choice stochasticity (for = 0, choices are random and as 183 increases, choices become more dependent on the option values). SV(SS t ) was fixed at 100 184 for the large magnitude condition and fixed at 20 for the small magnitude condition. I is again 185 the dummy-coded condition regressor, and sb models the magnitude effect on . The parameter a models the boundary separation (i.e. the amount of evidence required before 201 committing to a decision), t models the non-decision time (i.e., components of the RT related 202 to motor preparation and stimulus processing), z models the starting point of the evidence 203 accumulation process (i.e., a bias towards one of the response boundaries, with z>.5 reflecting 204 a bias towards the LL boundary, and z<.5 reflecting a bias towards the SS boundary) and n 205 models the rate of evidence accumulation. Note that for each parameter x, we also include a 206 parameter s x that models the change in that parameter from the high magnitude (SS=100) to 207 the low magnitude (SS=20) condition (coded via a the dummy-coded condition regressor I t ).
208
As in previous work 30,32,38 , we then set up temporal discounting diffusion models by making 
Results

247
Subjective and physiological drug effects 248 As reported in detail in our previous papers 28,29 , there were no significant group differences 249 with respect to reported side-effects, subjective mood, heart rate or blood pressure relative to 250 baseline. Likewise, groups did not differ with respect to the actual and guessed drug condition Model comparison 278 We next compared three versions of the drift diffusion model that varied in the way that they 279 accounted for the influence of value differences on trial-wise drift rates based on the deviance 280 information criterion (DIC) 41 . In each model, we included separate group level distributions 281 for the two drug conditions (Haloperidol vs. Placebo). Furthermore, for each parameter x, we The null model (DDM0) assumes fixed drift rates independent of value. We compared 287 this model to two variants of the DDM that assume that trial-wise drift rates depend on the 288 value-differences between options, either in a linear fashion (DDMlin) 32 or in a non-linear 289 (sigmoid) fashion 30, 38 . The data were best accounted for by the DDM with non-linear value-290 scaling of trial-wise drift rates (Table 2) . Overall group differences 302 We next examined overall group differences in model parameters for the baseline (smaller-303 sooner reward =100€) condition. Results are plotted in Figure 3 and Bayes Factors for all 304 group comparisons are listed in Table 3 . In both groups, there was a positive association 305 between trial-wise drift rates and value differences, as the 95% HDI for the drift rate 306 coefficient parameter vcoeff did not include 0 in either group (Figure 3b ). Likewise, there was a 307 slight bias towards the smaller-sooner option in both groups, as the 95% HDI for bias was 308 <0.5 in both cases (Figure 3e ). 309 We furthermore observed substantially lower group-level discount rates log(k) in the 310 haloperidol group compared to placebo, such that the 95% HDI of the posterior group Magnitude effects on model parameters 322 We next turned to the effects of the magnitude manipulation on diffusion model parameters, 323 that is, the change in each parameter in the 20€ condition compared to the 100€ baseline 324 condition. Results are plotted in Figure 4 and Bayes Factors for all group comparisons are 325 listed in Table 3 . There was a substantial magnitude effect on log(k), such that discounting pharmacological studies on DA contributions to temporal discounting 10,12,16,17 . Second, the 421 DDM-based modeling approach adopted in the present study (see above) allowed us examine 422 the dynamics underlying decision-making much more comprehensively than previous human 423 pharmacological studies 10,12-14,16,17 . In addition to the drug-effect on the discount rate log(k), with degrees of impulsivity in healthy control participants 66 (but see 65 for lack of evidence of 461 an association between D2 receptor density and temporal discounting in healthy controls).
462
The idea that reduced D2 receptor signaling is associated with both addiction and impulsivity 
468
The present study has a number of limitations that need to be acknowledged. First, we 469 did not run a within-subjects design, which would have allowed us to account for individual- Finally, in the present study, all rewards were hypothetical. It is common practice in many 475 studies on temporal discounting to e.g. randomly select a single trial following the testing 476 session and pay out the selected option for real 67,68 . Given the high magnitude condition SS reward can be estimated with high precision (red distribution). In contrast, LL value predictions are 688 assumed to be less precise than SS value predictions (black lines, the variance of these distributions is 689 overall lower than for the SS reward). An LL value prediction with lower precision (solid black line) 690 leads to a greater likelihood of SS choices even if the value prediction has the same mean, as 691 illustrated by the larger overlap between red and solid vs. dashed black distributions. 
